BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35755055)

  • 1. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema After Dexamethasone Implants.
    Huang YT; Chang YC; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Tsai YY
    Front Med (Lausanne); 2022; 9():852022. PubMed ID: 35755055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
    Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
    [No Abstract]   [Full Text] [Related]  

  • 3. Optical coherence tomography biomarkers in patients with macular edema secondary to retinal vein occlusion treated with dexamethasone implant.
    Castro-Navarro V; Monferrer-Adsuara C; Navarro-Palop C; Montero-Hernández J; Cervera-Taulet E
    BMC Ophthalmol; 2022 Apr; 22(1):191. PubMed ID: 35473615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive impact of optical coherence tomography biomarkers in anti-vascular endothelial growth factor resistant macular edema treated with dexamethasone implant.
    Horozoglu F; Sener H; Polat OA; Temizyurek O; Evereklioglu C
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103167. PubMed ID: 36261095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants.
    Visioli G; Alisi L; Mastrogiuseppe E; Albanese GM; Romano E; Iannetti L; Armentano M; Giovannetti F; Gharbiya M
    Int J Retina Vitreous; 2023 Jun; 9(1):35. PubMed ID: 37316930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
    Zur D; Iglicki M; Sala-Puigdollers A; Chhablani J; Lupidi M; Fraser-Bell S; Mendes TS; Chaikitmongkol V; Cebeci Z; Dollberg D; Busch C; Invernizzi A; Habot-Wilner Z; Loewenstein A;
    Acta Ophthalmol; 2020 Mar; 98(2):e217-e223. PubMed ID: 31421028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
    Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
    Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Coherence Tomography Predictors of Favorable Functional Response in Naïve Diabetic Macular Edema Eyes Treated with Dexamethasone Implants as a First-Line Agent.
    Meduri A; Oliverio GW; Trombetta L; Giordano M; Inferrera L; Trombetta CJ
    J Ophthalmol; 2021; 2021():6639418. PubMed ID: 33833870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in optical coherence tomography biomarkers in eyes with advanced idiopathic epiretinal membrane treated with dexamethasone implantation.
    Nie Z; Li W; Duan N; Wei J; Zhang X; Guo H; Bai S; Li X; Hu B
    BMC Ophthalmol; 2024 Feb; 24(1):54. PubMed ID: 38308204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and optical coherence tomography biomarkers as prognostic factors in dexamethasone intravitreal implant for diabetic macular edema.
    Oliverio GW; Meduri A; Brancati VU; Ingrande I; De Luca L; Raimondo ED; Minutoli L; Aragona E; Aragona P
    Eur J Ophthalmol; 2024 Feb; ():11206721241235242. PubMed ID: 38384119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
    Eandi CM; De Geronimo D; Giannini D; Polito MS; Tosi GM; Neri G; Le Mer Y; Varano M; Parravano M
    Acta Diabetol; 2020 Jul; 57(7):867-874. PubMed ID: 32114643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema.
    Velaga SB; Nittala MG; Alagorie AR; Marram J; Hu ZJ; Wang Z; Ciulla TA; Kapik B; Sadda SR; Ip M
    Can J Ophthalmol; 2024 Apr; 59(2):109-118. PubMed ID: 36803932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography Biomarkers in Bilateral Diabetic Macular Edema Patients with Asymmetric anti-VEGF Response.
    Koc F; Güven YZ; Egrilmez D; Aydın E
    Semin Ophthalmol; 2021 Aug; 36(5-6):444-451. PubMed ID: 33780313
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-life outcomes of intravitreal ranibizumab, aflibercept, and dexamethasone implant administrations in patients with treatment-naïve diabetic macular edema.
    Korkmaz A; Karti O; Zengin MO; Yuksel B; Kusbeci T
    Saudi J Ophthalmol; 2022; 36(3):327-334. PubMed ID: 36276250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Naïve Diabetic Macular Edema.
    Zhou J; Song S; Zhang Y; Jin K; Ye J
    Ophthalmol Ther; 2022 Dec; 11(6):2153-2167. PubMed ID: 36166152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
    Sun JK; Lin MM; Lammer J; Prager S; Sarangi R; Silva PS; Aiello LP
    JAMA Ophthalmol; 2014 Nov; 132(11):1309-16. PubMed ID: 25058813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
    Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorganization of Inner Retina and Outer Retinal Morphology in Diabetic Macular Edema.
    Das R; Spence G; Hogg RE; Stevenson M; Chakravarthy U
    JAMA Ophthalmol; 2018 Feb; 136(2):202-208. PubMed ID: 29327033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.